Download PDF
1 / Pages

Other users also viewed these articles

Risk factors for fibrosis progression in non-alcoholic steatohepatitis: Analysis of the European cohort in the real-world GAIN study Anum Shaikh; Gabriel Pedra; Leonardo Ruiz-Casas; Bethany Franks; Harpal Dhillon; João Diogo da Rocha Fernandes; Kamal Kant Mangla; Margarida Augusto; Manuel Romero-Gómez; Jörn M. Schattenberg;
Gastroenterol Hepatol. 2024;47:463-72
Advanced fibrosis associated with non-alcoholic steatohepatitis (NASH) in Spain: Results of a Delphi study Rocío Aller; José Luis Calleja; Javier Crespo; Manuel Romero-Gómez; Juan Turnes; Omar J. Benmarzouk-Hidalgo; Rafael Subirán; Alicia Gil;
Gastroenterol Hepatol. 2024;47:337-46
Vinpocetine represses the progression of nonalcoholic steatohepatitis in mice by mediating inflammasome components via NF-¿B signaling Yingwei Zhu; Hong Tang; Han Zhao; Jian Lu; Kai Lin; Jingbin Ni; Bo Zhao; Gaojue Wu; Chunxiao Tan;
Gastroenterol Hepatol. 2024;47:366-76